CHICAGO--(BUSINESS WIRE)--Genetic Immunity, a leader in plasmid DNA-based immunotherapies, and VectorBuilder, a global specialist in gene delivery solutions, announced a strategic partnership to ...
BUDAPEST, Hungary & SASSARI, Italy & PRINCETON, N.J.--(BUSINESS WIRE)-- James Chafouleas, Ph.D., former Head of Global Licensing – Virology at Boehringer Ingelheim Canada (Ltd.), has joined ...
Genetic Immunity (GI) Leverages VectorBuilder Partnership to Power Phase 3 HIV Vaccine Trials Genetic Immunity, a leader in plasmid DNA-based immunotherapies, and VectorBuilder, a global specialist in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback